Everything the adaptive question bank can teach and test in Pharmacy Law & Safety, from foundations through advanced practice. Work through it in order, or start practicing and let the questions find your level.
Placement reflects a judgment about abuse potential weighed against accepted medical use, so the schedule predicts the handling rules rather than the drug's strength. Tighter schedules bring tighter security and ordering.
Placement follows a formal process combining enforcement and medical evaluation, with a faster route where a substance appears urgently dangerous. Substances chemically similar to a scheduled one can be reached without listing each.
Three findings are weighed together, which is why a drug with real medical use can still sit in a restrictive schedule. The criteria are statutory, so a scheduling argument is made against them rather than against custom.
Some preparations are exempt or available without a prescription federally, and states routinely remove that option. Federal permission is a ceiling, not a guarantee of local availability.
Enforcement and medical evaluation sit with different agencies, so a scheduling decision combines two kinds of expertise. Knowing which agency does what explains why an approval and a schedule can diverge.
Each form exists for one event — ordering the most restricted stock, registering, reporting a loss, documenting destruction. Matching the event to the form is most of what is tested here.
A running count for the most restricted schedule allows a discrepancy to be noticed quickly, while a periodic full inventory establishes a baseline. The two serve different detection purposes.
The most restricted schedule requires an exact count; below that an estimate is permitted for smaller containers. The distinction reflects how much a diverted amount matters.
Inventories are taken at defined events — opening, on a recurring cycle, and when a drug newly becomes controlled — and taken consistently at the start or end of a day.
A running log only helps if variances are investigated rather than adjusted away, because an unexplained difference may be the first sign of diversion. Reconciling means explaining, not balancing.
Dispensing for opioid use disorder is structured differently depending on the setting and the registration involved. This is framework only; nothing here guides treatment of any patient.
Internal diversion shows up as patterns rather than single events — repeated small shortfalls, voided transactions, waste recorded without a witness. The pattern is the signal.
Refill authority narrows as the schedule tightens, to the point where the most restricted schedule permits none. The limits exist so repeat supply requires a fresh prescriber decision.
A control may be transferred between pharmacies on a limited basis, with a broader allowance where a shared real-time record exists. The record is what makes wider transfer safe.
The pharmacy shares responsibility for whether a prescription is legitimate, so dispensing is not a clerical act. Red flags oblige resolution before dispensing rather than after.
Where two rules both apply, the more restrictive governs, so compliance means satisfying both. Assuming a federal allowance settles the question is the standard error.
Stock may be secured in a substantial locked enclosure or dispersed through the general inventory, and the choice is judged on the whole security picture. Dispersal works by making stock hard to find.
Access to controlled stock carries screening and reporting duties, because most diversion involves someone already trusted with access. The controls assume an insider.
A query shows what was dispensed and reported, which is evidence about history and not proof of intent. Treating it as a verdict misuses it in both directions.
A common comparison measure allows different opioids to be discussed on one scale, alongside overdose-reversal access and risk-management programs. This is framing only, never guidance for any individual.
B. Other federal law
Requiring proof of safety before marketing followed a mass poisoning caused by an untested solvent. The law is the response to a specific catastrophe rather than an abstract principle.
Proof that a drug works, not merely that it is safe, was added after a birth-defect tragedy abroad. Adverse-event reporting arrived with it.
A generic can rely on the original efficacy evidence by demonstrating equivalence instead of repeating trials, which is what makes generic competition economically possible.
Therapeutic-equivalence ratings tell a pharmacist which products may be substituted, so the rating is the operative fact rather than the ingredient matching.
A shortage forces substitution decisions that would not otherwise arise, which makes it a safety event as well as a supply one. Reporting exists so the response can be coordinated.
Compendial standards gain legal force by being referenced in statute, which is how a private standards body's text becomes enforceable. The mechanism is incorporation, not enactment.
Where a drug's risk requires more than labeling, a structured program conditions access on defined steps. The program is part of the approval rather than an add-on.
An application permits human study, the phases progress from safety to effectiveness in larger groups, and a separate route allows access outside a trial. Each step answers a different question.
This is the amendment that created the prescription category, so the line between prescription and over-the-counter is statutory rather than customary. The caution legend marks which side a product is on.
One category compounds for an identified patient and the other produces at larger scale under stricter manufacturing expectations. Which applies determines what may be made and for whom.
Preparing for an identified patient is compounding; producing stock for unidentified future patients approaches manufacturing without approval. The patient-specific link is the dividing line.
Biologics are licensed under a different pathway, similarity is not identity, and an additional designation is required before substitution without prescriber involvement is possible.
Incentives exist because a small patient population cannot otherwise repay development. The designation describes the population's size, not the disease's severity.
Controls on samples and wholesale records exist because diverted samples re-entering the supply chain cannot be traced. The recordkeeping is the traceability.
Product outside the regulated chain has no verified handling history, so its identity and storage cannot be established. The objection is provenance rather than the product itself.
Documented transfers at each step mean a product's path can be reconstructed, which is what makes counterfeit entry detectable. Tracing is the control.
Severity classes reflect the probability of serious harm, which determines urgency and how far notification must reach. The class drives the response.
Behind-the-counter placement with identification and a log makes bulk purchasing visible across sales. The specific limits are time-sensitive and live in the vertical registry.
Child-resistant packaging is the default, with exceptions where rapid access matters more and a patient may waive it. The exceptions are principled rather than arbitrary.
One created the obligation to offer counseling; the other governs how health information is used and shared. Two different statutes, routinely confused because both touch the counter.
An improper inducement is anything of value intended to influence referrals or purchasing, and a claim that misrepresents what was supplied is separately actionable.
Practice is licensed by the state while drug products and controlled substances are federal concerns, so the two lanes address different questions. Registration and certification are also distinct.
C. Patient safety & quality assurance
These notations are error-prone because they are easily misread as something else entirely, producing a large dose error from a small ambiguity. Writing the word removes the failure mode.
Names that look or sound alike are picked wrongly under time pressure, and emphasizing the differing letters restores the visual difference the similarity removed.
These drugs are not more error-prone; they are more harmful when an error occurs. That distinction is why they get extra controls rather than extra care.
Classifying by the stage at which the error occurred points to the control that would have caught it. A near miss carries the same information without the harm.
Voluntary reporting only sees what is reported, so counts describe reporting behavior as much as underlying events. Their value is in patterns rather than totals.
Some tasks require professional judgment and cannot be delegated, and the boundary is defined by state law. This is framing; the actual scope is jurisdictional.
Separate standards cover nonsterile preparation, sterile preparation, and hazardous drug handling. Described here at the level of the publicly available summaries rather than quoted.
One is set by the manufacturer for an unopened container and the other is assigned when the product is prepared or repackaged. They answer different questions and are not interchangeable.
The framework names checks to perform, and performing them does not guarantee a correct outcome — it is a memory aid rather than a system. Treating it as a safety system is the flaw.
A dose can be misread by a factor of ten from a stray decimal or a misread unit abbreviation. The risk is concentrated in how the number is written rather than in the calculation.
Recording the reaction alongside the allergy lets a clinician judge severity, and an intolerance is a different clinical fact. Collapsing them loses information that changes decisions.
Certain circumstances prompt an offer, and questions requiring professional judgment belong to the pharmacist. Recognizing the trigger is the technician's part.
Events are categorized by the harm actually reached, not by how frightening the near-miss felt, so that severity data means the same thing between reporters.
The person at the sharp end acts within conditions created elsewhere, so a design flaw is a cause rather than an excuse. Stopping the analysis at the individual leaves the condition in place.
Harm requires holes in several layers to line up, so strengthening one layer leaves the same event available through the others. It argues for defense in depth.
Honest error, drifting into a risky shortcut, and conscious disregard are different behaviors deserving different responses. Treating all three alike stops people reporting.
Spoken orders lose the visual distinctions that separate similar drug names, so reading back and spelling restores them. It is a control for a specific, known failure.
Two identifiers are required because one can match more than one person, particularly with common names. The wrong-patient error is what the second identifier prevents.
Instructions that are not understood are not followed, so plain language and confirming understanding are safety controls rather than politeness.
D. Controlled-substance prescriptions & records
A missing element is not a formality, because each one establishes something about validity — who prescribed, for whom, what and how much. An incomplete prescription cannot be corrected by assumption.
Validity depends on the purpose behind the prescription and the prescriber acting in ordinary practice, so a technically complete form can still be invalid. Form is necessary, not sufficient.
The most restricted schedule normally requires a written or compliant electronic original, because a spoken order leaves no verifiable artifact. Exceptions exist and are narrow.
An emergency allows a spoken order limited to the emergency period, with a written version to follow. Both halves are required; the follow-up is not optional paperwork.
A few care settings permit a fax to serve as the original, chosen because the alternative delays care for patients who cannot wait. The settings are enumerated rather than general.
Separate prescriptions with staged earliest-fill dates are not refills — each is its own prescription, and treating them as refills misapplies every rule that follows.
Partial supply is permitted in defined circumstances with a window for the remainder, which exists so a supply shortfall does not become a treatment gap.
Partial fills are permitted within the existing refill window, with each documented so the total dispensed remains reconcilable against what was authorized.
Each refill is recorded with enough detail to reconstruct what was supplied and when, because the record is the only evidence during an audit or an investigation.
Both pharmacists record their side, so the transfer can be reconstructed from either end. A one-sided record leaves an unexplained gap in one pharmacy's count.
Electronic prescribing of controls requires proving who the prescriber is, a second authentication factor, and an audit trail — because the signature is otherwise trivially forgeable.
An agent may communicate a prescription the prescriber issued, but the decision to prescribe cannot be delegated. The distinction is between conveying and deciding.
A dispensed control is supplied for one named person, and the caution states that passing it to anyone else is unlawful. It appears on the label for that reason.
A federal framework permits pharmacist dispensing of certain products, and states generally narrow or remove it. The federal allowance does not settle what is permitted locally.
Where a concern cannot be resolved, the pharmacy documents and declines; simply handing the prescription back moves the problem without recording it. The record matters later.
Filing arrangements exist so controlled prescriptions can be separated for inspection, and the choice is about how readily each schedule can be produced.
The standard is that a record can be produced without undue effort, which constrains how records may be stored regardless of format. Existing somewhere is not enough.
E. DEA registration, ordering & disposal
Registration authorizes a specific activity, so a pharmacy's registration does not permit distribution or research. The activity defines the permission.
Each location registers separately, so stock and authority cannot be shared between sites. Moving product between locations is a distribution question.
A lapsed registration removes the authority to order or dispense, so renewal is an operational deadline rather than administrative housekeeping.
Employees acting within their duties are covered by the pharmacy's registration rather than registering individually, which is what makes ordinary staffing workable.
Authority to sign order forms is granted and revoked in writing, so the ability to order can be traced to a specific delegation. Revocation matters as much as the grant.
The form documents what was ordered, what was received and when, and an unfilled or partial order has defined handling. The copies are the reconciliation.
Digital certificates provide the identity assurance the paper form provided by signature, which is why electronic ordering can replace it.
Recording what actually arrived, against what was ordered, is where a shipment discrepancy becomes visible. Without it, a shortfall is indistinguishable from a later loss.
Records must be kept for a defined period and be available where the activity occurred, because an inspection reconstructs history from them.
Holding records centrally is permitted after notification, which exists so an inspector knows where to find them. Convenience is allowed; disappearance is not.
A theft or significant loss requires prompt notification and a formal report, and these are separate obligations rather than one. Filing the form late is its own failure.
Significance is judged on factors including the schedule, the quantity, the pattern and whether the loss is explainable, so it is a judgment documented at the time.
Destruction must be documented, witnessed and render the substance unrecoverable, because anything less leaves the material available to be diverted.
Sending unusable stock to a registered handler transfers the destruction obligation to someone equipped for it, which is why in-house destruction is the exception.
Inspections may proceed on consent or under a warrant, and understanding which applies is what makes the encounter procedurally correct on both sides.
F. Labeling, medication guides & packaging
The label must let the patient identify what they hold, who it is for and how to take it, without the original packaging. Each required element serves that.
One is regulated content approved with the product; the other is added by the pharmacy for this patient. Confusing them misattributes responsibility for what it says.
An auxiliary label should carry information the patient needs for this drug and route; applying them by habit dilutes the ones that matter.
A standardized format and order lets a consumer find the same information in the same place across products, which is what makes self-selection safer.
The document is structured so the most critical information appears first, with detail below. Knowing the structure is how a specific fact is found quickly.
It marks a risk serious enough to require prominence, which makes it a counseling trigger rather than a formatting choice.
Narrative sections replaced letter categories because a single letter compressed a nuanced risk-benefit judgment into something that read as a ranking.
Certain products require patient-directed information with every dispensing, so it is a dispensing step rather than an optional handout.
Some products require a guide because the risk information must reach the patient directly, and responsibility for providing it sits with the dispenser.
The dispensed date cannot outlast the stock container's, because repackaging cannot extend stability. It may be shorter for other reasons.
Machine-readable identification enables verification at the point of use, which is what allows a scan to confirm the product in hand.
Packaging must show whether it has been opened, so that a consumer can detect interference. The requirement followed deliberate product tampering.
Repackaged stock needs labeling sufficient to identify and date it once the original container is gone, because the original information no longer travels with it.
G. Privacy, payer rules & records
Health information becomes protected when it can be linked to an individual, so identifiers are what bring information within the rule. Removing them changes the analysis.
Disclosures should be limited to what accomplishes the purpose, with defined situations where the limit does not apply — such as a request from the patient themselves.
Core activities proceed without separate authorization because requiring one would make care impossible. The permission is broad and it has edges.
Some uses fall outside the core permission and need explicit written agreement, which is how marketing and most employer disclosures are handled.
The notice tells patients how information is used and what rights they have, and it must be made available rather than merely written.
Patients can obtain, seek correction of, and place limits on their information, and can ask to be contacted a particular way. These are enforceable rights rather than courtesies.
A patient can ask for a list of certain disclosures, with common operational ones excluded — which is why the list is shorter than people expect.
A vendor handling protected information on the pharmacy's behalf becomes subject to obligations through a written agreement, which extends the duty rather than transferring it.
Policies, physical controls and technical controls are three separate requirements, so encryption alone does not satisfy the obligation any more than a locked door does.
An impermissible use is assessed against defined factors to decide whether it is a breach, and the assessment itself is documented. Notification follows the finding.
Some overhearing is unavoidable in a pharmacy, so the requirement is reasonable safeguards rather than impossibility. Counter layout and screen placement are the controls.
The pharmacy's obligations differ by program, which is why the same dispensing can carry different documentation requirements depending on who pays.
An audit reconstructs what was dispensed and to whom, so the signature record and the patient profile are what defend the claim. Missing documentation reads as a missing dispensing.
H. Compounding safety — sterile, nonsterile & hazardous
These standards cover preparations where sterility is not required, defining categories that differ in how long a preparation may be used. Category drives the dating.
Where a preparation bypasses the body's barriers, the environment it is exposed to determines whether it stays sterile. That is why the air is the subject rather than the technique alone.
Handling standards follow the drug from arrival through disposal and apply to everyone who touches it, including receiving and housekeeping staff. Exposure is not limited to the compounder.
Cleanliness is defined by particle counts rather than by appearance, so a room is classified by measurement. Each space and device has a class it must maintain.
Each device protects something different — the preparation, the worker, or both — so choosing one is choosing what is being protected. Hazardous work requires worker protection.
The surrounding rooms support the device by controlling what enters, with a simpler arrangement permitted for limited preparations. The support is what makes the device effective.
Air moving away from a space protects what is inside it; air moving toward it protects what is outside. Hazardous work needs the second, which reverses the usual arrangement.
Garbing proceeds from the dirtiest items to the cleanest, with hand hygiene placed so it is not undone by what follows. Order is the control, not the items.
Critical sites must not be touched or shadowed, because the clean air reaching them is the only thing keeping them sterile. Blocking that air defeats the cabinet.
Categories reflect how much assurance exists that a preparation is sterile, and the permitted use period follows from that assurance. Immediate use is the narrowest case.
The date reflects sterility assurance, storage conditions and any testing performed, rather than chemical stability alone. It is a microbiological judgment first.
Water content, dosage form and storage drive the date, because water supports microbial growth and the form determines how protected the product is.
Testing demonstrates that a specific person can perform the work without contaminating it, which is why it is periodic and individual rather than a one-time qualification.
Sampling for particles and for growth answers two different questions, and an out-of-limit result requires investigation and action rather than a repeat sample.
Agent, contact time, sequence and frequency all matter, and an agent wiped off before its contact time has elapsed has not disinfected anything.
Protection is specified by material and by change interval, because permeation happens over time even without visible contamination. The interval is part of the protection.
These devices contain vapor and aerosol during transfer, and there are settings where their use is required rather than recommended. Containment is the function.
Containment comes before cleanup, because spreading the material is the larger risk. The kit exists so the sequence can be followed without improvisation.
One document is the formula and method; the other records what was actually made, by whom, and from which lots. The second is what supports an investigation.
A vial's permitted reuse depends on whether it contains a preservative, and an opened glass ampoule may shed fragments that must be filtered out.
I. Medication-safety systems & technology
A scan confirms the product identity and nothing about whether that product is right for this patient. Treating a successful scan as a full verification is the failure mode.
Independence means the second person does not see the first person's conclusion, because watching someone check produces agreement rather than verification.
Limits configured in the library are what turn a pump into a safety device, and the override record is where the limits are shown to be miscalibrated.
Standardizing removes per-order improvisation, which reduces both error and the cognitive load of noticing when something is unusual.
Electronic entry removes handwriting and transcription errors and introduces selection errors from adjacent list entries. It changes the error profile rather than removing errors.
An alert that usually does not matter trains people to dismiss alerts, so the volume of alerts is itself a safety variable. Fewer, better alerts are safer than more.
Physical separation defeats picking errors that look-alike packaging causes, because the wrong product is no longer within reach of the right one.
Transitions are where lists diverge, so comparing at each one catches omissions and duplications. Assigning ownership of the comparison is what makes it happen.
A structured method produces system actions rather than a conclusion about who was involved, which is the difference between analysis and attribution.
It examines a process before an event, ranking failure modes by severity, likelihood and how likely they are to be caught. It is proactive rather than reactive.
The loop closes when the change is verified, which is what separates improvement from a plausible intervention nobody measured.
Measuring near misses and interventions rewards noticing, while measuring reported errors alone punishes reporting. The metric changes the behavior it measures.
Access controls and the audit trail are what make a cabinet a control; an override list that is too broad removes the control while leaving the cabinet.
Automation makes consistent output, including consistently wrong output, so a human verification step remains and its placement decides what it can still catch.
Removing a high-harm product from general stock eliminates a class of error rather than reducing its likelihood. It is a control by absence.
J. Infection control & workplace safety
The choice depends on what is on the hands: visible soiling and certain organisms require washing, while a rub is otherwise effective and faster. Speed is why the rub matters.
Treating every contact as potentially infectious removes the need to guess who is infectious, which is the point — status is often unknown.
A written plan, training and a vaccination offer are separate obligations, and the plan must reflect the tasks actually performed rather than a template.
Engineering controls and safe practice work together, and recapping reintroduces the exposure the container was there to prevent. Point of use is where the container belongs.
Immediate steps and prompt reporting both matter, because some responses are time-limited. Delayed reporting can remove an option that was available at the time.
Protection is chosen for the hazard present, so wearing what is habitual can be both insufficient and, for a different hazard, irrelevant.
Streams are separated because they have different destinations and legal requirements, and mixing them makes the whole container take the strictest handling.
Workers have a right to know what they handle, delivered through labeling, accessible data sheets and training. The information must be available, not merely filed.
Equipment must be present, reachable within a short time, and tested, because an unreachable or untested station is equivalent to none during an incident.
Most pharmaceutical waste is not accepted down a drain because treatment systems do not remove it, so it reaches the environment. Convenience is not a disposal route.
Planning must cover temperature-sensitive stock as well as people, because a power loss is a product-integrity event alongside a safety one.
Cold-chain handling depends on unit placement and monitoring, and an excursion is a quality event requiring assessment rather than a judgment call at the fridge.
K. Prescription processing & verification duties
Each alert type asks a different question, so responding to all of them identically discards the information the type carries.
Duplication hides behind different names and combination products, so recognizing it requires looking at ingredients and class rather than product names.
A screen sees what is in the profile, which excludes purchases made elsewhere and anything bought without a prescription. Its blind spot is a counseling question.
A complete profile supports the checks that follow, and certain missing fields make a safe fill impossible rather than merely inconvenient.
Programs permit a technician to check technical accuracy, with tasks requiring professional judgment always excluded. The exclusions define the program.
Bin organization and an identity check at pickup exist because the last step is where the right prescription reaches the wrong person. Similar names are the risk.
What may return depends on whether custody and conditions can be assured, and the remaining dating follows the original. Some products can never return.
Checking legibility, completeness and authenticity before data entry stops an error being propagated through every subsequent step. It is the cheapest place to catch one.
A renewal restates what the prescriber authorized, so some elements may be updated administratively while the therapy itself may not be changed without them.
The final check compares what is in the container against the original prescription, in a defined sequence so nothing is assumed from an earlier step.
The log records that a specific prescription reached a specific person, which is where an audit starts and where a dispute is resolved.
Identity, temperature and controlled-substance constraints all follow the product out of the pharmacy, so delivery extends the pharmacy's obligations rather than ending them.
Some products may only be dispensed by enrolled pharmacies, so eligibility to dispense is itself a check before the prescription is processed.
L. Supply chain, recalls & inventory integrity
Documentation travels with the product at each transfer, which is what allows its history to be reconstructed. Without it the chain has a gap that cannot be closed later.
Buying only from verified licensed partners is what keeps unverified product out, so verification is a purchasing control rather than a formality.
A suspect finding triggers quarantine and investigation, so the product stops moving while the question is open. Continuing to dispense during the investigation defeats it.
Once the investigation concludes the product is illegitimate, notification duties follow — the finding is what converts an internal concern into a reportable event.
A returned package must have its identifier verified before resale, because a return is an opportunity for substituted product to enter the chain.
Arrival is the last point at which a shipment problem can be attributed to the supplier, so quantity, condition, temperature and paperwork are checked together.
Maintaining and documenting temperature makes an excursion detectable, and an excursion is a quality event requiring assessment rather than a judgment at the receiving door.
Who must be told depends on the recall's severity and reach, and whether patients are contacted is a decision made against that rather than a default.
Quarantine, reconcile quantities, return or destroy, and document — the last step is what closes the recall and evidences that it was completed.
These are distinct actions with different triggers and duties, so treating a withdrawal as a recall — or the reverse — applies the wrong obligations.
Package, label and documentation signals are what is available at the counter, since the product itself may look correct. The packaging is where the discrepancy shows.
Keentune is not affiliated with or endorsed by the organizations whose documentation informs these maps.
All exam, test, and product names and trademarks are the property of their respective owners and are used here for identification and reference only. Keentune is independent study practice — not affiliated with, authorized, or endorsed by any of these organizations.